Diclofenac Transdermal Patch Dosing
For topical diclofenac patch therapy, apply one 180 mg patch daily or one patch twice daily to the painful area. 1
Standard Dosing Regimen
The diclofenac transdermal patch is available as a 180 mg patch and should be applied according to the following protocol:
- Standard dose: One 180 mg patch applied once daily
- Alternative dosing: One patch twice daily (every 12 hours) for more severe pain
- Duration: Treatment typically continues for 60-90 days 1
The patch delivers diclofenac through the skin with minimal systemic absorption, providing localized anti-inflammatory effects at the site of application 1.
Clinical Context and Mechanism
Diclofenac patches work through inhibition of the cyclooxygenase pathway, reducing prostaglandin E2 synthesis 2. This topical formulation offers several advantages:
- Avoids first-pass metabolism and gastrointestinal complications common with oral NSAIDs
- Sustained drug delivery with steady plasma levels over prolonged periods
- Lower systemic bioavailability (approximately 0.22% compared to intramuscular injection) 3, which translates to reduced systemic side effects
- Flexibility - can be removed immediately if adverse effects occur
Application Guidelines
Apply the patch directly to the painful area:
- Clean and dry skin before application
- Change patch every 24 hours (or every 12 hours if using twice-daily dosing)
- Rotate application sites slightly to minimize skin irritation
- Maximum treatment duration studied is 90-180 days 2
Comparative Efficacy
While diclofenac patches demonstrate efficacy for pain management, they show more modest results compared to other topical NSAIDs or oral formulations 2. In comparative studies:
- Diclofenac gel showed 26-30% benefit over vehicle in actinic keratosis studies 2
- Complete clearance rates of 19.1-20% vs 0% for placebo 2
- Less intense local skin reactions than 5-FU or imiquimod, but matched by reduced efficacy 2
Important Caveats
Cardiovascular risk: All NSAIDs, including topical diclofenac, carry cardiovascular risks. Even low systemic absorption from patches may pose risks in patients with cardiovascular disease or risk factors 4. The cardiovascular risk appears similar across different diclofenac doses 5.
Not recommended in combination with cryosurgery for enhanced pain control, as studies show no additional benefit 6.
Plasma concentrations from transdermal patches (maximum 3-4 ng/mL) are well below IC50 values for COX-1 and COX-2, explaining the absence of dose-dependent systemic toxicities but also potentially limiting systemic analgesic effects 3.
For postoperative pain management in oral surgery, a single 100 mg transdermal patch provides effective analgesia for approximately 16 hours with mean VAS scores of 2, though oral diclofenac may be slightly more effective in the immediate postoperative period 7, 8.